61885-24-3 Usage
Type of Drug
Chemotherapy drug
Medical Use
Treats certain types of brain tumors, including glioblastoma multiforme and anaplastic astrocytoma
Mechanism of Action
Damages the DNA in cancer cells, leading to their destruction
Administration Route
Typically taken orally
Absorption
Well-absorbed by the body
Side Effects
Nausea, vomiting, fatigue, and low blood cell counts
Monitoring
Patients should be closely monitored by a healthcare professional while taking this medication
Check Digit Verification of cas no
The CAS Registry Mumber 61885-24-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,1,8,8 and 5 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 61885-24:
(7*6)+(6*1)+(5*8)+(4*8)+(3*5)+(2*2)+(1*4)=143
143 % 10 = 3
So 61885-24-3 is a valid CAS Registry Number.
61885-24-3Relevant articles and documents
Pyrimidine Derivatives and Related Compounds. Part 41. Reactions of 1,3,6-Trimethyl-5-nitrouracil and its 6-Bromomethyl Analogue with Amines and Hydrazines. Synthesis of Pyrazolopyrimidine N-Oxides and their Ring Expansion to Pyrimidopyrimid
Hirota, Kosaku,Yamada, Yoshihiro,Asao, Tetsuji,Senda, Shigeo
, p. 277 - 284 (2007/10/02)
Reactions of 1,3,6-trimethyl-5-nitrouracil (1) and 6-bromomethyl-1,3-dimethyl-5-nitrouracil (4) with amines and hydrazines have been studied with the aim of synthesising fused-ring pyrimidines.Treatment of compound (4) with primary amines afforded 2-subst
